- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Top medicine spending classes in developed pharmaceutical markets 2022
Top medicine spending classes in developed pharmaceutical markets 2022
Projected top therapy areas in developed pharmaceutical markets in 2022, by spending (in billion U.S. dollars)*
This statistic shows the top therapy areas in developed pharmaceutical markets as projected in 2022, sorted by spending in billion U.S. dollars. By 2022, expenditure on oncology in these markets is projected to reach between 115 and 130 billion U.S. dollars.
Projected top therapy areas in developed pharmaceutical markets in 2022, by spending (in billion U.S. dollars)*
Loading statistic...
Expand statistic
| Minimum estimate | Maximum estimate | |
|---|---|---|
| Oncology | 115 | 130 |
| Diabetes | 105 | 115 |
| Pain | 80 | 95 |
| Autoimmune | 65 | 75 |
| Respiratory | 40 | 50 |
| Antiobiotics and vaccines | 40 | 48 |
| Cardiovascular | 36 | 44 |
| HIV | 32 | 40 |
| Mental Health | 32 | 38 |
| Antivirals EX-HIV | 16 | 20 |
| Minimum estimate | Maximum estimate | |
|---|---|---|
| Oncology | 115 | 130 |
| Diabetes | 105 | 115 |
| Pain | 80 | 95 |
| Autoimmune | 65 | 75 |
| Respiratory | 40 | 50 |
| Antiobiotics and vaccines | 40 | 48 |
| Cardiovascular | 36 | 44 |
| HIV | 32 | 40 |
| Mental Health | 32 | 38 |
| Antivirals EX-HIV | 16 | 20 |
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
This statistic shows the top therapy areas in developed pharmaceutical markets as projected in 2022, sorted by spending in billion U.S. dollars. By 2022, expenditure on oncology in these markets is projected to reach between 115 and 130 billion U.S. dollars.
Show more- Show sources information
- Show publisher information
- Release date
- March 2018
- Region
- Worldwide
- Survey time period
- as of 2017
- Supplementary notes
-
* Forecast.
Note: Includes 8 developed and 6 pharmerging countries: U.S., EU5, Japan, Canada, China, Brazil Russia, India, Turkey, Mexico.
Source
- Show sources information
- Show publisher information
- Release date
- March 2018
More information
- Region
- Worldwide
- Survey time period
- as of 2017
- Supplementary notes
-
* Forecast.
Note: Includes 8 developed and 6 pharmerging countries: U.S., EU5, Japan, Canada, China, Brazil Russia, India, Turkey, Mexico.
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Diabetes
- 76 page/s
- English
- pptx
- Detailed references
Everything On "Diabetes" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Statista is a great source of knowledge, and pretty helpful to manage the daily work.Christof Baron
CEO, MindShare Germany
Statistics on "Diabetes"
- Global overview
The most important statistics
- Leading causes of death worldwide in 2016 (in millions)Global death rate - leading causes 2016
- Estimated number of diabetics worldwide in 2017 and 2045 (in millions)Diabetics worldwide 2017 and 2045
- Percentage of diabetics in the global adult population in 2017 and 2045Diabetics prevalence worldwide 2017 and 2045
- Number of diabetics worldwide in 2017 and 2045, by age group (in millions)*Number of diabetics worldwide by age group 2017 and 2045
- Number of diabetics worldwide in 2017, by region (in millions)Number of diabetics worldwide by region 2017
- Difference between the actual percentage of adults aged 20 to 79 worldwide who had diabetes and what respondents believed as of 2017Assumed diabetes prevalence vs. reality in select countries worldwide as of 2017
- Countries and regions
The most important statistics
- Countries with the highest number of diabetics worldwide in 2017 (in millions)Countries with the highest number of diabetics 2017
- Countries with the highest prevalence of diabetes worldwide in 2017*Countries with the highest prevalence of diabetes 2017
- Prevalence of diabetes among adults in selected countries as of 2017Diabetes prevalence adults in selected countries 2017
- Global undiagnosed diabetes cases by region in 2017 (in millions)Undiagnosed diabetes cases globally by region 2017
- Percentage of diabetics undiagnosed in world regions in 2017Share of undiagnosed diabetics by world region 2017
- Costs
The most important statistics
- Leading 10 countries with highest spending per patient with diabetes in 2017 (in U.S. dollars)Top 10 countries with highest spending per person with diabetes 2017
- Leading 10 countries with lowest spending per patient with diabetes in 2017 (in U.S. dollars)Top 10 countries with lowest spending per person with diabetes 2017
- Cost per patient with diabetes worldwide by region in 2017 (in U.S. dollars)Average cost per person with diabetes globally by region 2017
- Health care expenditure due to diabetes worldwide in 2017, by region (in billion U.S. dollars)Health care expenditure due to diabetes worldwide by region 2017
- Top 10 countries based on diabetes health expenditure in 2017 (in billion international dollars)Diabetes health expenditure top 10 countries in 2017
- Healthcare expenditures to treat diabetes in the U.S. and China in 2017 (in billion international dollars)Healthcare expenditures due to diabetes in the U.S. and China 2017
- Estimated global healthcare expenditure to treat diabetes in 2017 and 2045 (in billion U.S. dollars)Global healthcare expenditure due to diabetes in 2017 and 2045
- Diabetes care market
The most important statistics
- Top 10 diseases worldwide by number of active drugs in 2018*Worldwide top diseases 2018, by number of active drugs
- Global pharmaceutical revenue of anti-diabetic products from 2008 to 2017 (in billion U.S. dollars)Global revenue of anti-diabetic products 2008-2017
- Top 10 pharmaceutical companies by global anti-diabetic revenue in 2017 and 2024 (in million U.S. dollars)Global anti-diabetic revenue by top ten pharmaceutical companies 2017 and 2024
- Top 10 pharmaceutical companies based on anti-diabetics market share worldwide in 2017 and 2024*Global market share of top pharma companies by anti-diabetic revenue 2017 and 2024
- Top anti-diabetic products worldwide based on revenue in 2017 and 2024 (in million U.S. dollars)*Top worldwide anti-diabetic products prediction by revenue 2017 and 2024
- Top anti-diabetic products worldwide based on market share in 2017 and 2024Top worldwide anti-diabetic products by market share 2017 and 2024
- Deaths
The most important statistics
- Number of deaths before the age of 60 due to diabetes worldwide in 2017, by region (in millions)Number of diabetes deaths worldwide 2017, by region
- Number of deaths caused by selected chronic diseases worldwide as of 2016 (in 1,000)Deaths caused by chronic diseases 2016
- Leading 10 causes of death in upper income countries in 2016 (in deaths per 100,000 population)Top ten causes of deaths in upper income countries 2016
- Leading 10 causes of death in upper-middle income countries worldwide in 2016 (in deaths per 100,000 population)Top ten causes of deaths in upper-middle income countries 2016
- Outlook
The most important statistics
- Projected number of diabetics worldwide in 2045, by region (in millions)Projected number of diabetics worldwide by region 2045
- Increase in number of diabetics worldwide between 2017 and 2045, by regionChange in number of diabetics between 2017 and 2045 by world region
- Countries with the highest projected number of diabetics worldwide in 2045 (in millions)Countries with the highest projected number of diabetics 2045
- Projected top therapy areas in developed pharmaceutical markets in 2022, by spending (in billion U.S. dollars)*Top medicine spending classes in developed pharmaceutical markets 2022
Popular Related Keywords
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Top specialty therapy spending in developed pharmaceutical markets 2020
- Select medicine spending classes in developed pharma markets 2020
- Impact of patent expiry - developed pharmaceutical markets 2008-2017
- Select medicine classes in pharmerging markets by spending forecast 2020
- Projection of new active substance distribution by disease 1996-2020
- Projection of new active substance availability by type 1996-2020
- CAGR by product type in pharmaceutical markets forecast 2018-2022
- Developed and emerging pharmaceutical markets - specialty spending 2012-2017
- Pharmaceutical spending distribution by product type and market 2022
- Top therapy spending areas in pharmerging markets 2018
- Global pharmaceutical market by top therapeutic classes 2009-2012
- Global pharmaceutical market revenue 2008-2015
- Retail prices of selected pharmaceuticals in Sweden 2008-2015
- Spending on pharmaceuticals in the United Kingdom (UK) 2003-2014
- World pharmaceutical select subsector value share 2017
- Breakdown of French drug exports in European countries 2016
- Pharmaceutical industry revenues in PIIGS countries 2011-2020
- Market value of the prescription acne drug market in the U.S. 2015-2016, by category
- Leading electrotherapy device brands in the U.S. 2016, based on sales share
- Leading electrotherapy device brands in the U.S. 2016, based on sales
Studies
- Pharmaceutical market in Italy
- Pharmaceutical market in Sweden
- Pharmaceutical market in Norway
- Pharmaceutical industry in Denmark
- Pharmaceutical industry in Norway
- Pharmaceutical industry in Sweden
- Pharmaceutical trends in Europe
- Pharmaceutical industry in Mexico
- Global pharmaceutical industry
- Pharmaceutical industry in the United Kingdom (UK)
- Canadian pharmaceutical industry
- Orphan drugs
- U.S. pharmaceutical industry
- Medicines Use and Spending in the U.S. - A Review of 2016 and Outlook to 2021
- EP Vantage 2019 Preview
Statistics on "Diabetes"
- Leading causes of death worldwide in 2016 (in millions)
- Estimated number of diabetics worldwide in 2017 and 2045 (in millions)
- Percentage of diabetics in the global adult population in 2017 and 2045
- Number of diabetics worldwide in 2017 and 2045, by age group (in millions)*
- Number of diabetics worldwide in 2017, by region (in millions)
- Difference between the actual percentage of adults aged 20 to 79 worldwide who had diabetes and what respondents believed as of 2017
- Countries with the highest number of diabetics worldwide in 2017 (in millions)
- Countries with the highest prevalence of diabetes worldwide in 2017*
- Prevalence of diabetes among adults in selected countries as of 2017
- Global undiagnosed diabetes cases by region in 2017 (in millions)
- Percentage of diabetics undiagnosed in world regions in 2017
- Leading 10 countries with highest spending per patient with diabetes in 2017 (in U.S. dollars)
- Leading 10 countries with lowest spending per patient with diabetes in 2017 (in U.S. dollars)
- Cost per patient with diabetes worldwide by region in 2017 (in U.S. dollars)
- Health care expenditure due to diabetes worldwide in 2017, by region (in billion U.S. dollars)
- Top 10 countries based on diabetes health expenditure in 2017 (in billion international dollars)
- Healthcare expenditures to treat diabetes in the U.S. and China in 2017 (in billion international dollars)
- Estimated global healthcare expenditure to treat diabetes in 2017 and 2045 (in billion U.S. dollars)
- Top 10 diseases worldwide by number of active drugs in 2018*
- Global pharmaceutical revenue of anti-diabetic products from 2008 to 2017 (in billion U.S. dollars)
- Top 10 pharmaceutical companies by global anti-diabetic revenue in 2017 and 2024 (in million U.S. dollars)
- Top 10 pharmaceutical companies based on anti-diabetics market share worldwide in 2017 and 2024*
- Top anti-diabetic products worldwide based on revenue in 2017 and 2024 (in million U.S. dollars)*
- Top anti-diabetic products worldwide based on market share in 2017 and 2024
- Number of deaths before the age of 60 due to diabetes worldwide in 2017, by region (in millions)
- Number of deaths caused by selected chronic diseases worldwide as of 2016 (in 1,000)
- Leading 10 causes of death in upper income countries in 2016 (in deaths per 100,000 population)
- Leading 10 causes of death in upper-middle income countries worldwide in 2016 (in deaths per 100,000 population)
- Projected number of diabetics worldwide in 2045, by region (in millions)
- Increase in number of diabetics worldwide between 2017 and 2045, by region
- Countries with the highest projected number of diabetics worldwide in 2045 (in millions)
- Projected top therapy areas in developed pharmaceutical markets in 2022, by spending (in billion U.S. dollars)*
- Top specialty therapy areas in developed pharmaceutical markets by spending in 2020 (in billion U.S. dollars)*
- Selected therapy areas in developed pharmaceutical markets by spending in 2020 (in billion U.S. dollars)*
- Impact of patent expiry in developed pharmaceutical markets from 2008 to 2017 (in billion U.S. dollars)
- Selected therapy areas in pharmerging markets by spending in 2020 (in billion U.S. dollars)*
- Projected distribution of global available new active substances by disease type between 1996 and 2020*
- Projected global available new active substances by substance type between 1996 and 2020*
- Projected pharmaceutical spending CAGR worldwide between 2018 and 2022, by market and product type*
- Spending on specialty pharmaceuticals in developed and emerging pharmaceutical markets from 2012 to 2017 (in billion U.S. dollars)
- Global pharmaceutical spending distribution in 2022, by market and product type*
- Top therapy areas in pharmerging markets in 2018, by spending (in billion U.S. dollars)*
- Top therapeutic classes on the global pharmaceutical market from 2009 to 2012 (in billion British pounds)*
- Global pharmaceutical market revenue from 2008 to 2015 (in billion U.S. dollars)*
- Average retail prices of selected pharmaceuticals in Sweden in 2008 and 2015 (in SEK)
- Annual spending on pharmaceuticals in the United Kingdom (UK) between 2003 and 2014 (in U.S. dollars per capita)
- Pharmaceutical value share distribution by select subsector worldwide as of 2017
- Distribution of French exports of medicines to Europe in 2016, by country
- Value of the pharmaceutical sales in the so-called PIIGS* countries from 2011 to 2020 (in billion U.S. dollars)
- Market value of the branded prescription acne drug market in the United States in 2015 and 2016, by category (in billion U.S. dollars)
- Sales share of the leading electrotherapy device brands in the United States in 2016
- Leading electrotherapy device brands in the United States in 2016, based on sales (in million U.S. dollars)
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Please log in to access our additional functions
Register in seconds and access exclusive features.
Basic Account |
Instant Access
Premium Account | ||
|---|---|---|---|
Our servicesClick the question mark for further information | Free |
$49 per month* | |
| Basic statistics | |||
| Premium statistics | |||
|
Graph download
| |||
| Download PDF | |||
|
Excel download
| |||
| Register | Purchase now | ||
*Duration: 12 months, billed annually, single license
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.